Muhammad Shuja, MD

Mayo Clinic Rochester
Rochester, MN

Muhammad Shuja is currently a PGY4 radiation oncology resident at the Mayo Clinic in Rochester, Minnesota. His research interests include particle therapy, specifically the role of proton therapy in recurrent and complex scenarios. Dr. Shuja completed a radiation oncology residency in Saudi Arabia, as well as an Advanced Radiation Oncology Fellowship at the Mayo Clinic, before pursuing residency training in the US.

Disclosures:

• Employment: Mayo Clinic:Resident Physician:Employee
• Compensation: :Role Topic Description-End Date:
• Ownership: none
• Leadership: none

Presentation(s):

• 104 - Conventional vs. Hypofractionated Proton Postmastectomy Radiotherapy: Patient Reported Outcomes from a Randomized Phase 2 Trial

  Sunday, September 29, 2024
  8:40 AM – 8:50 AM ET

• 3072 - A Prospective Pilot Study of Cardiac MRI (cMRI) for Evaluation of Early Cardiac Toxicity in Patients Receiving Neoadjuvant Chemoradiotherapy (nCRT) for Esophageal Cancer

  Tuesday, October 1, 2024
  12:45 PM – 2:00 PM ET

• 1075 - Patient Reported Outcomes after Chemoradiation with IMPT vs. IMRT for Patients with Anal Canal Squamous Cell Carcinoma

  Tuesday, October 1, 2024
  4:25 PM – 4:30 PM ET